Open AccessErratum: Anti-Granulocyte–Macrophage Colony–Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial
Publication year - 2022
Publication title -
american journal of respiratory and critical care medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.272
H-Index - 374
eISSN - 1535-4970
pISSN - 1073-449X
DOI - 10.1164/rccm.v206erratum9
Subject(s) - medicine , covid-19 , pneumonia , monoclonal antibody , placebo , randomized controlled trial , granulocyte macrophage colony stimulating factor , double blind , immunology , antibody , virology , pathology , cytokine , outbreak , alternative medicine , disease , infectious disease (medical specialty)